Dublin, Oct. 19, 2017 (GLOBE NEWSWIRE) -- The "Global Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.

Global injectable drug delivery is projected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.

Scope of the Report

• The global injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.
• Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices.
• The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.
• On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.
• The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn's disease, psoriasis and others.
• Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.
• On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.
• On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.
• On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.

Becton Dickinson and company is going to dominate the injectable drug delivery market following with Pfizer and Baxter International, Inc.

Market Overview

Drivers

• Rising Cases of Chronic Diseases
• Rising Demand of Self-Injection Devices
• Growth of Biologics Market
• Technological Advancements and Innovations in Drug Delivery Market

Restraints

• Needlestick Injuries and Infections
• High Cost of Development
• Strict Regulatory Framework

Opportunity

• Increasing Demand for Generic and Biosimilar Drugs
• Increasing Demand for Contraceptive Injectables
• Increasing Demand for Self-Administration of Drugs

Challenges

• Alternative Route of Drug Administration
• Product Recall
• Stability of Products
• Sterility of Injections

Key Topics Covered:

1. Introduction

2. Market Segmentation

3. Market Overview

4. Executive Summary

5. Premium Insights

6. Global Injectable Drug Delivery Market, Regulatory

7. Global Injectable Drug Delivery Market, by Type

8. Global Injectable Drug Delivery Market, by Application

9. Global Injectable Drug Delivery Market, by Usage Pattern

10. Global Injectable Drug Delivery Market, by Mode of Administration

11. Global Injectable Drug Delivery Market, by End User

12. Global Injectable Drug Delivery Market, by Distribution Channel

13. Global Injectable Drug Delivery Market, by Geography

14. Global Injectable Drug Delivery Market, Company Share

15. Company Profiles

• Alkermes Plc.
• Baxter International, Inc.
• Becton Dickinson
• Bespak, Antares Pharma
• Elcam Medical
• Eli Lilly and Company
• Gerresheimer AG
• Haselmeier
• Mylan N.V.
• Novo Nordisk
• Owen Mumford Ltd
• Pfizer
• Sandoz
• Sanofi
• Schott AG
• Terumo Corporation
• Teva Pharmaceuticals Industries Ltd.
• West Pharmaceutical Services, Inc
• Ypsomed Holding AG.

For more information about this report visit https://www.researchandmarkets.com/research/mghfqf/global_injectable

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Infusions and Injectables